Showing results (791-800 of 1,006) with videos related to
Sort By:
Pageof 101
Ejhaem|May 7, 2025
Prevalence of CCR7-Positive CD8 T Cells as a Prognostic Factor in B-Cell Maturation Antigen -Targeted Chimeric Antigen Receptor T Cell TherapyYoshiaki Marumo, Masaki Ri, Toru Ebina, et al.Ejhaem|April 25, 2025
Prophylactic versus on-demand transfusion in pregnant women with sickle cell disease: A systematic review and meta-analysis of randomised controlled trialsDenise Menezes Brunetta, Evangelia Vlachodimitropoulou, Nita Prasannan, et al.Ejhaem|May 1, 2025
Belantamab Mafodotin Monotherapy for Multiply-Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of IrelandEdmund C R Watson, Faouzi Djebbari, Fotios Panitsas, et al.Ejhaem|November 10, 2025
Warm Autoimmune Haemolytic Anaemia Management in Asia-Pacific: A Delphi Panel Expert Consensus and Systematic Literature ReviewPhil Choi, Alberta Hoi, Rong Fu, et al.Ejhaem|November 10, 2025
Radiologic Pseudoprogression Associated With a Positive Response in a Patient With Multiple Myeloma Treated With a BCMA×CD3 Bispecific Antibody: A Case ReportAbdullah M Khan, Glenn S Kroog, Tito Roccia, et al.Ejhaem|August 11, 2025
Successful Allogeneic Stem Cell Transplant for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia After Pneumonectomy for Pulmonary Mucormycosis: A Case Report and Review of the LiteratureAlexander O'Hara, Sanja Zepcan, Stephanie Tsai, et al.Ejhaem|August 11, 2025
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCTTakashi Toya, Yujiro Nakajima, Konan Hara, et al.Ejhaem|September 10, 2025
SGLT-2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T-Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes-Related Hematological MalignancyKazuho Morichika, Keita Tamaki, Takuya Fukushima, et al.Ejhaem|October 16, 2025
Uncommon Evolution From Acute Myeloid Leukaemia to JAK2-Mutated Myeloproliferative Neoplasm: Evidence of Clonal Persistence and Divergence From TET2/SRSF2-Mutated Haematopoietic ProgenitorsMark Anthony Turingan, Ehsan Bahrami Hezaveh, Cuihong Wei, et al.Pageof 101